Evaluation of Vepoloxamer in Chronic Heart Failure

Summary

The purpose of this study is to evaluate whether vepoloxamer can provide a blood chemical marker and functional benefit to damaged heart muscle cells. This will be evaluated by measurement of blood-based laboratory markers, exercise tolerance, and echocardiograms. In addition, the safety and blood levels of vepoloxamer in subjects with chronic heart failure will be evaluated.

Timeline

Start

2015-10

Primary completion

2016-10

Completion

—

Outcome

Outcome not reported

Stopped: “Terminated for administrative reasons not related to safety or efficacy”

Drugs

Indications